Intrathecal Gene Therapy For SLC13A5 Citrate Transporter Disorder
Intrathecal Gene Therapy For SLC13A5 Citrate Transporter Disorder
Recruiting · NCT07102524 · Registry updated 2026-06-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intrathecal Gene Therapy For SLC13A5 Citrate Transporter Disorder | developmental and epileptic encephalopathy, 25 | Recruiting | Phase 1 / Phase 2 | 2026-06-30 | NCT07102524 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| TESS Research Foundation | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Texas Southwestern Medical Center | Dallas | United States | 2 |